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Abstract. 
 
Expression of the basement membrane 
heparan sulfate proteoglycan (HSPG), perlecan (Pln), 
mRNA, and protein has been examined during murine 
development. Both Pln mRNA and protein are highly 
expressed in cartilaginous regions of developing mouse 
embryos, but not in areas of membranous bone forma-
tion. Initially detected at low levels in precartilaginous 
areas of d 12.5 embryos, Pln protein accumulates in 
these regions through d 15.5 at which time high levels 
are detected in the cartilage primordia. Laminin and 
collagen type IV, other basal lamina proteins commonly 
found colocalized with Pln, are absent from the carti-
lage primordia. Accumulation of Pln mRNA, detected 
by in situ hybridization, was increased in d 14.5 em-
bryos. Cartilage primordia expression decreased to lev-
els similar to that of the surrounding tissue at d 15.5. 
Pln accumulation in developing cartilage is preceded by 
that of collagen type II. To gain insight into Pln function 
in chondrogenesis, an assay was developed to assess the 
potential inductive activity of Pln using multipotential 
10T1/2 murine embryonic ﬁbroblast cells. Culture on 
Pln, but not on a variety of other matrices, stimulated 
extensive formation of dense nodules reminiscent of 
embryonic cartilaginous condensations. These nodules 
stained intensely with Alcian blue and collagen type II 
antibodies. mRNA encoding chondrocyte markers in-
cluding collagen type II, aggrecan, and Pln was elevated 
in 10T1/2 cells cultured on Pln. Human chondrocytes 
that otherwise rapidly dedifferentiate during in vitro 
culture also formed nodules and expressed high levels 
of chondrocytic marker proteins when cultured on Pln. 
Collectively, these studies demonstrate that Pln is not 
only a marker of chondrogenesis, but also strongly po-
tentiates chondrogenic differentiation in vitro.
Key words: heparan sulfate proteoglycan • perlecan • 
chondrogenesis
 
C
 
ARTILAGE
 
 serves as a multifunctional tissue in the
vertebrate body. It is found in adult structures,
providing a flexible support in the nose, trachea,
spine, and rib tips. Found also in the developing embryo,
cartilage provides a framework for endochondral bone
formation. During embryonic development, subsets of
mesenchymal cells generate hypertrophic chondrocytes
through a stepwise progression of chondrogenesis. This
process begins with mesenchymal cell condensation. As
condensed cells further differentiate into chondroblasts,
collagen expression transitions from type I to type II
(Castagnola et al., 1988). Further maturation into hyper-
trophic chondrocytes is marked by the expression of ag-
grecan and collagen type X (Kirsch and von der Mark,
1990; Elima et al., 1993). In endochondral bone formation,
ossification of cartilage follows. In the search for chondro-
genic factors, a variety of growth factors have been exam-
ined. Basic FGF (bFGF),
 
1
 
 TGF-
 
b
 
1, and its family mem-
bers, BMP-2 and -4, are the most commonly used growth
factors for in vitro assays of chondrocyte differentiation.
BMP-2 is of particular interest in chondrogenesis due to its
ability to induce bone in vitro via an endochondral path-
way (Katagiri et al., 1990; Wang et al., 1990; Wozney et al.,
1990) and osteoblastic maturation in vitro (Yamaguchi et
al., 1991). During development, BMP-2 mRNA is ex-
pressed in the dorsal condensing mesenchyme and later in
the periosteum and osteogenic zone. TGF-
 
b
 
1 is also de-
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tected in the periosteum as well as in other bone cells and
tissues (Lehnert et al., 1988). In vitro assays demonstrated
that TGF-
 
b
 
1 can stimulate the formation of chondrocytes
(Rosen et al., 1988; Frenz et al., 1991; Denker et al., 1995;
Basic et al., 1996). BMP-4, another TGF-
 
b
 
 family member,
is a mesodermal inducing factor in 
 
Xenopus
 
, and is re-
quired for the formation of mesoderm in mice (Winnier et
al., 1995). As a promoter of mesodermal induction, BMP-4
might stimulate the condensation of mesenchyme, initi-
ating the cascade of chondrogenesis. Along with these
TGF-
 
b
 
 superfamily members, bFGF is also thought to in-
duce differentiation in mesodermal cells (Smith, 1993).
Cartilage is known to contain a variety of proteoglycans
primarily carrying glycosaminoglycan chains other than
heparan sulfate (HS). Aggrecan, decorin, biglycan, and fi-
bromodulin are well studied chondroitin sulfate (CS),
keratan sulfate, and dermatan sulfate proteoglycans, re-
spectively, found in chondrocyte matrix (Roughley and
Lee, 1994). Recently, the HS proteoglycan perlecan (Pln)
has been identified as a component of chondrocyte matrix
(Iozzo et al., 1994; SundarRaj et al., 1995; Handler et al.,
1997). Syndecan-2, a cell surface HS proteoglycan, also has
been identified in chondrocytes (David et al., 1993). Both
Pln and syndecan-2 carry HS chains in cartilage (David et
al., 1993; SundarRaj et al., 1995).
Previous studies with cultures of chick limb bud mesen-
chymal cells proposed a role for HS in formation and
growth of chondrogenic regions. When these cells were
cultured in the presence of soluble HS or heparin (HP),
the numbers of aggregates and 
 
35
 
S-sulfate incorporation
increased. This effect was dependent on HS chain struc-
ture, size, and charge. CS, lacking 
 
L
 
-iduronic acid, and less
sulfated than HS derivatives, had little activity in this as-
say. The presence of HS or HP was proposed to promote
the growth of the aggregates through assisting in forma-
tion of tighter aggregates, thereby detaching the cells from
matrix molecules that would maintain cells in a less differ-
entiated state (SanAntonio et al., 1987).
In this study, the pattern of Pln protein and mRNA ex-
pression during murine development was examined. High
levels of Pln protein were detected in developing cartilage
and compared with cartilage markers such as collagen type
II and Alcian blue staining, an index of proteoglycan ac-
cumulation. Because of their multipotential nature, the
mouse embryonic fibroblast cell line 10T1/2 has been used
extensively in assays to study the developmental progres-
sion of chondrogenesis and osteogenesis in vitro (Taylor
and Jones, 1979; Konieczny and Emerson, 1984; Ahrens
et al., 1993; Gazit et al., 1993; Wang et al., 1993; Atkinson
et al., 1997). Assays using this cell line, as well as human
chondrocytes, demonstrate that Pln can both stimulate
and maintain chondrogenic differentiation in vitro, sug-
gesting a similar potentiating role in vivo.
 
Materials and Methods
 
Materials
 
CF-1 mice were obtained from Sasco. Laminin, rabbit anti–mouse lami-
nin, fibronectin, collagen type IV (Col IV), rabbit anti–mouse collagen
type IV, Matrigel, Pln, human recombinant bFGF, TGF-
 
b
 
1, and rabbit an-
tibody to human bFGF, which does not cross-react with mouse bFGF,
were all obtained from Becton Dickinson Labware. Rat mAb against
mouse Pln and mouse mAb to a Col II peptide sequence, recognizing both
mouse and human epitopes, were purchased from Chemicon Interna-
tional, Inc. Rabbit polyclonal antibody against rat aggrecan, recognizing
mouse and human aggrecan, was provided by Dr. Kurt Doege (Shriner’s
Hospital for Children Portland Unit). Mouse mAb to chicken Col II (anti-
body II-II6B3 used at 1:100 dilution, which recognizes mouse collagen
type II) was obtained from the Developmental Studies Hybridoma Bank
maintained by the Department of Pharmacology and Molecular Sciences,
Johns Hopkins University School of Medicine (Baltimore, MD), and the
Department of Biological Sciences, University of Iowa (Iowa City, IA)
under contract N01-HD-6-2915 from the NICHD. HP, HP-BSA, bovine
kidney HS (BK-HS), bovine intestinal mucosa HS (BIM-HS), CS, hyal-
uronidase, heparin sulfate proteoglycan, ascorbic acid, sodium pyruvate,
and sodium citrate were obtained from Sigma Chemical Co. Species-spe-
cific, fluorescein-conjugated secondary antibodies were purchased from
Amersham Corp. The mouse Pln cDNA (clone 5) was the generous gift of
Dr. John Hassell (Shriners’ Hospital, Tampa Bay, FL). BMP-2 and -4 and
Balb-c 3T3 cells were the generous gifts of Drs. Randy Johnson and
Benoit de Crombrugghe (University of Texas, M.D. Anderson Cancer
Center, Houston, TX), respectively.
 
Immunofluorescent Detection of Extracellular
Matrix Components
 
Under the I.A.U.C.C. approved guidelines for animal use, CF-1 female
mice were subjected to superovulation by intraperitoneal injection of 5 IU
pregnant mare serum gonadotropin followed by 5 IU human chorionic go-
nadotropin (hCG) 48 h later. After hCG injection, females were caged
with stud males overnight. Females were inspected the next morning for
vaginal plugs, indicating d 0.5 of pregnancy at noon. Uteri and embryos
were collected on various days of pregnancy. The tissue was snap frozen in
isopentane chilled by dry ice and stored at 
 
2
 
70
 
8
 
C. 8-
 
m
 
m sections cut on a
Reichert-Jung cryostat were allowed to air dry briefly and stored at 
 
2
 
70
 
8
 
C
until they were processed. Immunostaining was carried out as described
previously (Carson et al., 1993). Sections were not decalcified before
staining. In brief, sections or wells were fixed in 100% methanol for 10
min at room temperature, washed with Dulbecco’s PBS without magne-
sium or calcium (D-PBS) twice for 5 min each, incubated with the primary
antibody for 1 h at 37
 
8
 
C, washed with D-PBS three times for 5 min each,
incubated with the secondary antibody for 45 min at 37
 
8
 
C, washed with
D-PBS three times for 10 min, and mounted. Samples were stored in the
dark at 
 
2
 
20
 
8
 
C until they were photographed on a Leitz microscope
equipped for epifluorescence. Some sections were pretreated with hyal-
uronidase to ensure no epitopes were masked. Frozen sections were
washed in PBS three times for 4 min each before treatment with hyal-
uronidase (4 mg/ml in PBS, pH 5) at 37
 
8
 
C for 30 min. After treatment, sec-
tions were washed for 4 min in PBS and the standard staining procedure
described above was followed, starting with fixation in methanol. Detec-
tion of HS chains in the tissue was performed as described previously
(Carson et al., 1993). In brief, methanol fixed sections were rehydrated in
0.15 M NaCl, 20 mM EDTA, and 10 mM Tris, pH 8 (TEN), and incubated
with human recombinant bFGF (0.05 
 
m
 
g/ml in TEN) for 2 h at 37
 
8
 
C in a
humid chamber. Sections were then washed with TEN three times for 5
min each at room temperature, incubated with rabbit anti–human bFGF
for 1 h at 37
 
8
 
C, washed again as before, incubated with FITC-conjugated
donkey anti–rabbit antibody for 40 min at 37
 
8
 
C, washed three times for 10
min each, and mounted in glycerol/PBS (9:1, vol/vol) buffered to pH 8
with 0.5 M sodium carbonate buffer, pH 9, and containing 0.1% (wt/vol)
 
p
 
-phenylenediamine.
 
Detection of Pln mRNA by In Situ Hybridization
 
Embryos were isolated on either d 14.5 or d 15.5 of pregnancy and frozen
as described above. In situ hybridization was performed as described pre-
viously (Smith et al., 1997). The Pln probe was prepared as described pre-
viously (Smith et al., 1997). In brief, linearized Pln cDNA clone 5 was used
in an in vitro transcription kit from Ambion Inc. Probes were purified us-
ing phenol/chloroform extraction and ethanol precipitation. Hydrolysis to
reduce probe size was performed and afterwards probes were resus-
pended in 10 mM Tris-HCl, pH 7.5, 1 mM EDTA, and 10 mM dithiothrei-
tol and stored at 
 
2
 
70
 
8
 
C until use.
10-
 
m
 
m frozen sections were prepared as described above and used in in
situ hybridization as described (De et al., 1989; McMaster et al., 1992).
Sections were not decalcified before use. In brief, sections were fixed in
4% (wt/vol) paraformaldehyde for 15 min after thawing. Each sample was 
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incubated with 2 
 
3
 
 10
 
7
 
 cpm/ml 
 
35
 
S-labeled riboprobe after prehybridiza-
tion and covered with a siliconized coverslip. After hybridization at 45
 
8
 
C
for 4 h, sections were digested with RNase A (20 
 
m
 
g/ml) at 37
 
8
 
C for 15
min. After 2 wk of autoradiography with Kodak NTB-2 emulsion, hybrid-
ized probe was visualized after development. Sections were counter-
stained with hematoxylin and eosin.
 
Culture of 10T1/2 Cells or Human Chondrocytes on 
Various Matrix Components
 
Tissue culture dishes of either 4 wells (Nunc) or 24 wells (Corning) were
coated with 5 
 
m
 
g each of the following matrix components: Pln (9 nmol/
well), HP (330 nmol/well), HP-BSA (HP chains covalently linked to BSA,
41 nmol/well), BSA (75 nmol/well), bovine intestinal mucosa HS (660
nmol/well), collagen type IV (16 nmol/well), laminin (5 nmol/well), fi-
bronectin (11 nmol/well), or Matrigel. For coating wells, 5 
 
m
 
g of the ma-
trix component was added to the well followed by D-PBS to attain a total
volume of 200 
 
m
 
l. The area of wells in either the 4- or 24-well dishes is 1.76
cm
 
2
 
 (4-well plates from Nunc, Nunclon, Cat. No. 176740; 24-well plates
from Costar Corp., Cat. No. 3524). Matrigel was applied undiluted to the
well as a thin layer and excess was removed immediately. The plate was
allowed to dry overnight at 37
 
8
 
C. In all cases, on the following day wells
were washed twice with D-PBS before adding cells. Coating efficiency was
determined by including 
 
125
 
I-iodine labeled Pln at the time of coating and
counting material rinsed from the wells. Bound Pln gave a coating density
of 1.5 
 
m
 
g Pln/cm
 
2
 
.
Murine 10T1/2 cells obtained from ATCC were maintained as subcon-
fluent cultures in tissue culture flasks with Dulbecco’s modified Eagle’s
media/Ham’s F12 (1:1) media containing 100 mg/ml streptomycin sulfate,
100 U/ml penicillin, 1.2 g/liter NaHCO
 
3
 
, and 15 mM Hepes (pH 7.2) sup-
plemented with 10% (vol/vol) heat-inactivated FBS. For matrix assays,
cells were detached with trypsin/EDTA (Irvine Scientific) and plated on
matrix-coated wells in CMRL-1066 media supplemented with antibiotics
and either high (15% [vol/vol]) or low (2.5% [vol/vol]) FBS for prelimi-
Figure 1. Detection of Pln in
uteri and embryos by indirect
immunofluorescence. Fro-
zen sections of implantation
sites of d 7.5 (A) and d 8.5
(B) mouse uteri, and d 11.5
(C) and d 15.5 (D) mouse
embryos were probed with a
mAb to Pln core protein. Pln
is detected in the muscular
and vascular elements of the
uterus and in many extracel-
lular matrices of the em-
bryos. Arrowheads in the d
15.5 embryo indicate the car-
tilage primordia, which dis-
play high levels of Pln core
protein. (A and B) d, de-
cidua; m, myometrium; mm,
mesometrial aspect of uterus;
l, lacunae; e, embryo. (C and
D) a, amnion; h, H, heart; s,
somites; B, brain; l, L, liver.
Magnification is indicated on
the figure. 
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nary experiments. In later experiments, the media was supplemented with
15% (vol/vol) FBS, pyruvate (50 
 
m
 
g/mg), citrate (50 
 
m
 
g/ml), and ascorbic
acid (50 
 
m
 
g/ml). Plating density was 2 
 
3
 
 10
 
5
 
 cells per well (114,600 cells
per cm
 
2
 
). Media was added to bring the total volume in a well to 500 
 
m
 
l.
Media was changed every other day during assays. For growth factor as-
says, growth factors were added at 1 ng/ml (bFGF, BMP-2 at 0.055 nM,
TGF-
 
b
 
1 at 0.2 nM, and BMP-4 at 0.063 nM) to CMRL-1066 supplemented
with 15% (vol/vol) FBS, citrate, ascorbate, and pyruvate. Medium was
changed every other day and a fresh aliquot of growth factor added.
Human costochondral cartilage samples were acquired from pectus ex-
cavatum surgeries after appropriate consent was obtained and with insti-
tutional IRB approval. Cartilage samples were minced and digested in col-
lagenase, 2 mg/ml, overnight at 37
 
8
 
C. The chondrocytes were plated and
grown in DMEM with 15% FBS. All chondrocytes were expanded in
monolayer cultures, and used at passage 3.
Formation of aggregates was assessed by visual examination using a mi-
croscope. Cells that had drawn together into dense, multi-layered regions
reminiscent of condensing mesenchyme of developing cartilage, leaving
areas of the well bare, were scored as aggregate positive. Also, cells in
these regions were highly rounded compared with the fibroblastic mor-
phology typical of 10T1/2 cells. To determine whether expression of chon-
drocyte markers was uniform throughout the aggregate mass, aggregates
 
formed on Pln were fixed in paraformaldehyde, embedded in cryopro-
tectant, and sectioned. Alcian blue staining was performed before embed-
ding. Sections were processed for immunostaining as described for tissue
sections. Cells grown on plastic were similarly treated and scraped off the
plate before embedding.
 
Enzymatic Digestion of Glycosaminoglycan
(GAG) Chains
 
Wells were coated with Pln, as described above. Before plating of 10T1/2
cells, wells were subjected to digestion with chondroitinase ABC (Sigma
Chemical Co.) or a mix of heparinases I, II, and III (Sigma Chemical Co.).
To each well, 0.25 ml of enzyme mix containing 1 U/ml enzymes, 0.5 mM
Mg
 
2
 
1
 
/Ca
 
2
 
1
 
, a protease inhibitor mixture (PIMS I described in Pimental
et al., 1996) in D-PBS was added. Plates were incubated at 37
 
8
 
C for 4 h.
After digestion, wells were rinsed with D-PBS before plating cells. As a
control, 0.5 ml of CS or HP at 1 mg/ml was treated with enzyme or with
buffer lacking enzyme for the same time. After digestion of control solu-
tions, 1/10 volume 10% (wt/vol) cetylpyridinium chloride was added to
precipitate and visualize GAGs to confirm enzyme activity. A successful
digest resulted in at least 50% reduction of precipitated GAGs in the di-
gested control compared with undigested. To determine if digestion re-
Figure 2. Pln accumulation
in cartilage primordia. Lon-
gitudinal, frozen sections
from embryos at d 12.5 (A
and B), d 13.5 (C and D), and
d 14.5 (E and F) were probed
with a mAb to Pln (A, C, and
E) or similar regions were
stained with hematoxylin and
eosin (B, D, and F). Regions
of developing vertebrae are
shown. Pln protein levels
were low in the cartilage pri-
mordia (arrows) at d 12.5,
but accumulated as develop-
ment progressed through d
13.5 and d 14.5. In contrast,
consistent, discrete expression
of Pln is noted in surround-
ing tissues. Bars, 200 mm. 
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moved Pln from wells, digested and undigested Pln wells were subjected
to an ELISA binding assay. No loss of Pln protein core through digestion
was detected by this assay.
 
Identification of Chondrocytic Phenotype by Alcian 
Blue Staining
 
10T1/2 cells were cultured for 10 d on various matrices, washed twice with
D-PBS, and fixed for 15 min in 10% (wt/vol) paraformaldehyde in PBS.
After fixation, cells were washed twice with ultrapure water before Alcian
blue (1% [wt/vol]) in 0.1 N HCl was added to the cells for 30 min. Cells
were washed twice with 0.1 N HCl and allowed to dry. Photography was
performed on a Nikon inverted microscope using bright-field conditions.
 
RNA Extraction
 
After culture for various times on different matrices, RNA was isolated
from 
 
z
 
4 
 
3
 
 10
 
5
 
 10T1/2 cells per treatment using the method of Chomczyn-
ski and Sacchi (1987). After determining the concentration of RNA for
each sample, reverse transcription and polymerase chain reactions (RT-
PCR) were performed.
 
Analysis of Gene Expression by RT-PCR
 
PCR primers for various chondrocyte markers were acquired from
GIBCO-BRL. Collagen type I 
 
a
 
2: forward 5
 
9
 
 GAACGGTCCACGAT-
TGCATG 3
 
9
 
, reverse 5
 
9
 
 GGCATGTTGCTAGGCACGAAG 3
 
9
 
; col-
lagen type II 
 
a
 
1: forward 5
 
9
 
 CACACTGGTAAGTGGGGCAAGACCG
3
 
9
 
, reverse 5
 
9
 
 GGATTGTGTTGTTTCAGGGTTCGGG 3
 
9
 
 (Shukunami
et al., 1996); aggrecan: forward 5
 
9
 
 CTACGACGCCATCTGCTACA 3
 
9
 
,
reverse 5
 
9
 
 ACGAGGTCCTCACTGGTGAA 3
 
9
 
 (Doege et al., 1987); Pln:
forward 5
 
9
 
 CCTACGATGGCCTTTCCCT 3
 
9
 
, reverse 5
 
9
 
 TTGGCACT-
TGCATCCTCCA 3
 
9
 
 (Smith et al., 1997). First-strand cDNA was synthe-
sized with total RNA extracted from cultured cells by random hexamer
priming using an RNA PCR kit (Perkin Elmer). In brief, purified total
RNA (840 ng) was incubated at 42
 
8
 
C for 60 min with a mixture of 1 U of
RNase inhibitor, 2.5 U of MuLV reverse transcriptase, 2.5 
 
m
 
M of random
hexamers, 5 mM MgCl
 
2
 
, 10 mM Tris-HCl (pH 8.3), 50 mM KCl, and 1 mM
each of dGTP, dATP, dTTP, and dCTP in a volume of 20 
 
m
 
l.
Aliquots of 1/10 (2 
 
m
 
l) of the cDNA were used to amplify coding se-
quences from type I and type II collagen, Pln, and aggrecan. The PCR
conditions for collagen types I and II were 94
 
8
 
C for 30 s, 60
 
8
 
C for 1 min,
72
 
8
 
 for 1 min for 25 cycles, and final extension at 72
 
8
 
C for 5 min. The PCR
conditions for Pln and aggrecan were 94
 
8
 
C for 30 s, 55
 
8
 
C for 30 s, 72
 
8
 
C for
1.5 min for 25 cycles, and 94
 
8
 
C for 30 s, 68
 
8
 
C for 30 s, 72
 
8
 
C for 1.5 min for
25 cycles, respectively. The products were separated by electrophoresis
through 4% Nusieve 3:1 agarose gels (FMC Bio Products) along with mo-
lecular weight markers and detected by ethidium bromide. PCR products
were subsequently sequenced and determined to be specific for either Col
I or Col II.
 
Results
 
Pln Expression in Development
 
The expression pattern of Pln protein at various stages of
postimplantation development was analyzed by immuno-
histochemistry (Fig. 1). During early postimplantation
stages, Pln was consistently detected in muscular elements
such as the uterine myometrium and the developing heart
in the embryo. In the d 7.5 uterus (Fig. 1 A) Pln was ex-
pressed in basal lamina of vascular elements, basement
membrane of the epithelial cells of the residual lumen, in
the amnion surrounding the embryo, and the embryo it-
self. At d 8.5, Pln protein was detected surrounding vascu-
lar elements in the decidua of the uterus and had accumu-
lated to high levels in the developing lacunae (Fig. 1 B) as
well as in the extracellular matrix of the decidua itself. At
d 8.5, staining of the embryo persisted while extraembry-
onic tissue was negative. At later stages of development
Pln protein is detected in basal lamina throughout the em-
bryo (Fig. 1, C and D). Staining within the liver is seen,
again defining vascular elements. The amnion (bottom-
most region, Fig. 1 C), consisting of two distinct layers sep-
arated by a basal lamina, stains intensely with anti-Pln.
Muscular tissue such as the tongue and heart are positive,
as are regions of the brain such as the choroid plexus. No-
tably, by d 15.5 of development, Pln staining was particu-
larly intense in developing cartilage including the ribs and
the cartilage primordia (Fig. 1 D). Membranous bone re-
gions were negative for Pln staining.
To further examine the temporal expression of Pln in
developing cartilage primordia, longitudinal sections con-
taining dorsal regions from d 12.5, d 13.5, and d 14.5 were
stained with Pln antibody (Fig. 2). While at d 12.5 (Fig. 2
A) Pln is essentially undetectable in the condensing inter-
vertebral disc, by d 13.5 (Fig. 2 B) an initial accumulation
of Pln was detectable. By d 14.5 (Fig. 2 C), Pln signal was
clear and discretely localized within the discs, as well as in
basal lamina of surrounding tissues. In situ hybridization
confirmed that Pln mRNA accumulation also occurred in
developing cartilage primordia (Fig. 3). At d 14.5, the
level of Pln mRNA in cartilage primordia was higher than
the surrounding tissue (Fig. 3 A). Sense cRNA probes
Figure 3. Pln mRNA expres-
sion in d 14.5 embryos. In situ
hybridization was performed
with Pln antisense (A) and
sense (B) riboprobes. A re-
gion of the embryo including
the cartilage primordia (ar-
rows) is shown. The expres-
sion of Pln mRNA is higher in
the discs than in the surround-
ing tissue (A). This expres-
sion is specific as determined
by absence of signal with the
sense control (B). Refer to
Fig. 2 E for histological refer-
ence. Bar, 100 mm. 
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demonstrated negligible background hybridization signal
(Fig. 3 B).
 
Other Basal Lamina Components Are Not Expressed by 
Cartilage Primordia
 
After examining Pln expression in cartilage primordia, im-
munohistochemistry was used to determine if other basal
lamina proteins, namely collagen type IV and laminin, also
accumulated in these regions. As shown in Fig. 4, in the d
15.5 embryo, Pln protein levels were high (Fig. 4 A), while
neither collagen type IV (Fig. 4 B) nor laminin (Fig. 4 C)
accumulated in the discs, although these proteins were
readily detectable in the surrounding tissue. Predigestion
of sections with hyaluronidase had no effect on Pln stain-
ing and did not reveal collagen type IV or laminin staining
(data not shown). Thus, these observations indicated that
general accumulation of basal lamina components did not
occur in developing cartilage. Immunostaining with anti-
bodies to collagen type II demonstrated that accumulation
of this early cartilage marker protein preceded that of Pln.
As shown in Fig. 5, at d 11.5 of development cartilaginous
condensations are moderately positive for collagen type II
(Fig. 5 A), but negative for Pln (Fig. 5 B). By d 12.5, a sim-
ilar region is strongly positive for collagen type II (Fig. 5
C) accompanied by low levels of Pln (Fig. 5 D). These ob-
servations suggested that while Pln expression is a compo-
nent of the program of ongoing chondrogenesis, it is not
an initial marker of this process.
At d 15.5 Pln accumulation persisted in the cartilage pri-
mordia regions (Fig. 6 A). As expected, these same struc-
tures strongly stained with Alcian blue (Fig. 6 B), consis-
tent with the cartilaginous nature of this tissue. These
structures also stained positively for HS using a bFGF-
dependent HS detection system (Fig. 6 C). Staining by
bFGF was completely blocked by inclusion of soluble HP
(Fig. 6 D), thus indicating that HS chains rather than FGF
protein receptors were the major ligands detected in the
tissue. In contrast to the pattern observed at d 14.5, in situ
hybridization performed at d 15.5 did not show a preferen-
tial accumulation of Pln mRNA in cartilage primordia rel-
ative to the surrounding tissue (Fig. 6 E, arrowheads). This
finding indicated that persistent, high-level Pln mRNA ex-
pression was not required for persistent, high-level Pln
protein retention in developing cartilage.
 
In Vitro Assays of Chondrogenic Differentiation
 
Given the dramatic accumulation of Pln in developing car-
tilage, it was considered that Pln might potentiate the
chondrogenic process. Initially, 10T1/2 cells were plated
on a variety of matrices and visually inspected for morpho-
logical changes typical of chondrogenesis, i.e., aggregate
formation. When plated on tissue culture plastic (Fig. 7
A), 10T1/2 cells maintained their fibroblastic phenotype.
If plated on Pln, cells became rounded and aggregated into
nodules that stained positively with Alcian blue (Fig. 7, B
and D). A scoring index was developed to describe differ-
ent behaviors observed during in vitro culture and is de-
scribed in Table I. Of a variety of extracellular matrix
components studied, only Pln and, to a lesser extent, the
Pln-containing complexes in Matrigel were able to induce
nodules (Table I). While heparinase digestion severely re-
duced Pln’s activity in this regard, HP, HS, or HP-BSA
displayed very little activity, indicating that both the pro-
tein and HS chains of Pln are required. 10T1/2 cells plated
on a variety of other matrices or tissue culture plastic
maintained a fibroblastic phenotype. Some Pln prepara-
tions from sources other than Becton Dickinson did not
display this activity, presumably due to differences in HS
chain composition (see below). Various potential chon-
Figure 4. Laminin and collagen type IV are not expressed in car-
tilage primordia. Frozen sections of d 15.5 embryos were probed
with antibodies to the basal lamina components Pln (A), collagen
type IV (B), or laminin (C) by indirect immunofluorescence.
While discrete sites of surrounding tissue react consistently with
all three antibodies, only Pln is expressed in cartilaginous re-
gions. Bar, 100 mm. 
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drogenic growth factors, including BMP-2, BMP-4, bFGF,
and TGF-
 
b
 
1, were added to the culture medium of cells
plated on inactive Pln preparations and failed to induce
aggregate formation (Table II). Moreover, extraction of
Pln-coated surfaces with high salt, a procedure expected to
remove HS-bound growth factors, had no effect on aggre-
gate formation (Table I). Thus, contamination of “active”
Pln preparations with these growth factors did not account
for its chondrogenic activity. Interestingly, Balb-c 3T3
cells, plated on active Pln, form aggregates, but many of
these aggregates remained Alcian blue negative. Thus,
while other embryonic fibroblastic cell lines respond to
Pln, there appear to be differences in the degree of this re-
sponse (see below). 10T1/2 cell aggregates also accumu-
lated large amounts of collagen type II (Fig. 7 F) as well as
aggrecan (data not shown). In contrast, 10T1/2 cells cul-
tured on tissue culture plastic failed to accumulate col-
lagen type II (Fig. 7 E). Aggregates sectioned and probed
for chondrocyte markers were positive for matrix mole-
cules such as collagen type II and aggrecan (Fig. 8, C and
D). Alcian blue staining was also present in the aggregate
(Fig. 8 A). Hematoxylin and eosin staining show distinc-
tive nonfibroblastic morphology when cultured on Pln
(Fig. 8 B) compared with 10T1/2 cells cultured on plastic
(Fig. 8 F). Cells cultured on plastic again express little col-
lagen type II (Fig. 8 E). RT-PCR analyses of RNA iso-
lated from 10T1/2 cells cultured on Pln also demonstrated
increased expression of collagen type II mRNA (Fig. 9).
Plating of 10T1/2 cells on Pln digested with heparinase,
to remove HS chains, resulted in delayed and incomplete
aggregation into nodules (Fig. 10 D). In contrast, nodule
formation was both rapid and complete on chondroiti-
nase-digested Pln (Fig. 10 C) and was indistinguishable
from undigested Pln (Fig. 10 B). ELISA demonstrated
that neither heparinase nor chondroitinase digestion re-
duced the amount of Pln protein core bound to the tissue
culture surfaces (data not shown). The kinetics and extent
of differentiation on Pln is described in Fig. 11. 10T1/2
cells efficiently aggregated within 1 d of culture on Pln and
became uniformly Alcian blue positive within 4 d. Chon-
droitinase digestion had no effect on these parameters
while heparitinase digestion severely and persistently re-
tarded all aspects of this process. Collectively, these in
vitro studies indicated that while the protein core of Pln
participates in promotion of chondrogenesis, the HS
chains also are required for maximal activity. Further-
more, different embryonic fibroblast cell lines display dif-
ferent degrees of Pln responsiveness.
To examine the behavior of stable chondrocytes on Pln,
human chondrocytes were plated on tissue culture plastic
or Pln and examined for the expression of aggrecan or col-
lagen type II. On plastic, human chondrocytes appeared fi-
broblastic (Fig. 12, B and G) and expressed lower levels of
aggrecan (Fig. 12 A). In contrast, chondrocytes on Pln
formed aggregates (Fig. 12, D and H) maintaining their
rounded morphology, and accumulated high levels of ag-
grecan (Fig. 12 C). Similar to murine 10T1/2 cells, human
chondrocytes cultured on Pln also accumulated high levels
of collagen type II (Fig. 12 F). When human fibroblasts are
cultured on Pln, they fail to attach (Fig. 12 E).
 
Discussion
 
As a component of extracellular matrix and basal lamina,
Pln is found in various embryonic and adult tissues. The
major cartilage proteoglycans are of the chondroitin/der-
matan sulfate variety; however, expression of Pln has been
reported recently (Iozzo et al., 1994; SundarRaj et al.,
1995; Handler et al., 1997). While the Pln core protein has
the ability to carry CS chains, it has been demonstrated
that Pln in cartilage also carries HS chains (SundarRaj
et al., 1995). Consistent with these findings, we detected
both Pln protein and mRNA as well as HS chains in devel-
oping mouse cartilage. One description of Pln expression
Figure 5. Collagen II expres-
sion precedes that of Pln in
developing embryos. Sec-
tions from d 11.5 (A and B)
and d 12.5 (C and D) were
probed with antibodies to
collagen type II (II6B3) (A
and C) and Pln (B and D).
At d 11.5, collagen type II is
detectable in the spinal re-
gion while Pln is undetect-
able. By d 12.5, collagen type
II is intense and Pln is be-
ginning to accumulate. Bar,
100  mm. 
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during embryonic development has been reported (Han-
dler et al., 1997), with similar results to those presented
here. An examination of Pln expression throughout mu-
rine development demonstrated a relationship with chon-
drogenesis. During this process, Pln protein was found to
accumulate in the cartilage primordia progenitor cells.
This does not reflect a general expression of basal lamina
components by the cells, since neither laminin nor col-
lagen type IV was detected in these tissues. (In contrast,
laminin has been found in human nasal cartilage [Sunder-
Raj et al., 1995].) A hallmark of chondrocyte differentia-
tion, collagen II expression, was apparent by d 12.5, a time
when Pln was only faintly detected. Thus, these cells ap-
pear to be committed to initial aspects of the chondrocytic
pathway before displaying high level Pln expression. It is
possible that low levels of Pln accumulate before collagen
type II and trigger further chondrocytic differentiation in
vivo. In this regard, 10T1/2 cells and human chondrocytes
also respond to culture on Pln by expressing high levels of
Pln themselves (data not shown). Alternatively, Pln ex-
pression may be independent of collagen type II or Pln
may promote more complete differentiation of cells al-
ready poised to undergo chondrogenesis. 10T1/2 cells re-
spond more rapidly and completely than Balb-c 3T3 cells.
Similarly, human chondrocytes, but not human fibroblasts,
can respond to Pln in vitro. It is not clear what factors, e.g.,
cell surface receptors, transcription factors, etc., predis-
pose cells to Pln responsiveness.
Initial assays determined that 10T1/2 plated on Pln and,
to a lesser extent, the Pln-containing matrix, Matrigel,
formed aggregates and stained positively with Alcian blue.
The ability of 10T1/2 cells to undergo chondrogenic differ-
entiation in vitro may be enhanced by the chondrogenic
transcription factor, SOX9 (Bell et al., 1997). In develop-
ing cartilage, SOX9 expression precedes that of Pln (Bell
et al., 1997). Interestingly, 10T1/2 cells express much
higher levels of SOX9 than Balb-c 3T3 cells (Lefebvre et al.,
1997). This may account, in part, for the ability of 10T1/2,
but not 3T3 cells to differentiate more completely in re-
sponse to Pln; however, 3T3 cells stably transfected with
SOX9 form aggregates, but fail to stain with Alcian blue as
completely as 10T1/2 cells (data not shown). Collectively,
these data suggest that while SOX9 may be necessary, it is
not sufficient to promote chondrogenesis either alone or
in combination with Pln.
As described previously, other extracellular matrix mol-
Figure 6. Analysis of carti-
lage primordia of d 15.5
embryo. (A) Pln expression,
determined by immunostain-
ing, is high in the cartilage
primordia. To define charac-
teristics of these discs, em-
bryos were stained with Al-
cian blue (B). The positive
Alcian blue staining is indic-
ative of proteoglycan accu-
mulation characteristic of
cartilaginous tissue. The sur-
rounding tissue is negative
for Alcian blue staining. (C)
Deposition of HS in cartilage
primordia was determined by
staining with bFGF as de-
scribed in Materials and
Methods. HS is seen in the
discs and the chondrocytes as
well as in the surrounding tis-
sue. The specificity of stain-
ing for HS is demonstrated
by competition with HP in-
cluded during the staining
procedure (D). By this stage
of development, no prefer-
ential accumulation of Pln
mRNA in developing carti-
lage was apparent by in situ
hybridization with Pln anti-
sense probe (E). Sense probe
signal was similar to that
seen in Fig. 5 (data not
shown). Bright-field pho-
tography (F) of the same
site confirms the location of
the discs (arrowheads). Bars,
100 mm. 
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ecules and glycosaminoglycans fail to induce differentia-
tion. Heparinase-treated Pln displayed inductive ability,
albeit at a greatly reduced rate compared with intact Pln.
These experiments indicate that cooperation between the
Pln core protein and its constituent HS chains occurs in
the potentiation of chondrogenesis. To exclude action of
potential contaminating growth factors, certain inactive
Pln preps, obtained from either commercial sources or
prepared in our laboratory, were supplemented with growth
factors previously proposed as chondrogenic agents, i.e.,
bFGF, BMP-2, BMP-4, and TGF-
 
b
 
1. These potential con-
taminants failed to stimulate nodule formation on inactive
Pln preparations. It was surprising that neither BMPs nor
TGF-
 
b1 stimulated chondrogenesis on surfaces coated
with inactive Pln since these growth factors do so when
10T1/2 cells are cultured under other conditions (Katagiri
et al., 1990; Denker et al., 1995; Atkinson et al., 1997). The
assay developed here relies on the response of the cells to
a matrix molecule presented in a solid phase, presumably
similar to the state found in vivo. The features differentiat-
ing inactive Pln from the active preparations have not yet
been clarified. However, it is clear that both the GAG
chains and the protein core participate in this activity.
Damage to the protein core or HS chain alteration, e.g.,
heparanase digestion or undersulfation, might result in a
lack of activity in the 10T1/2 assay. We have found that
chondrogenic activity maps to particular recombinant Pln
domains and requires glycosaminoglycans (French, M., M.
Hook, R. Timpl, and D.D. Carson, unpublished observa-
tions). It is possible that, in the absence of appropriate gly-
cosaminoglycan chains, portions of cell surface receptors
or binding sites become occupied that require glycosami-
noglycan interactions to transmit signals fully. FGF recep-
tors require such interactions with HS chains in complexes
with FGFs (Yayon et al., 1991; Aviezer et al., 1994; Kan et
al., 1996). In the absence of appropriate glycosaminogly-
can complexes at these sites, cells may become locked in a
state preventing them from responding to other signals. In
addition, the observation that the Pln that is active in solid
phase assays is inactive in soluble form also indicates that
the context of Pln presentation is an important aspect of
this response. The receptors involved in Pln recognition by
10T1/2 cells must be identified to understand these re-
sponses in molecular detail.
Rinsing of Pln-coated surfaces with high salt concentra-
tions, a treatment that would be expected to release HS-
Figure 7. Detection of chondro-
cyte markers in 10T1/2 cells. Af-
ter culture on tissue culture plas-
tic (A, C, and E) or Pln (B, D,
and F) for 9 d, 10T1/2 cells
maintained a fibroblastic ap-
pearance on tissue culture plas-
tic (A) but formed aggregates
(B) on Pln reminiscent of mes-
enchymal condensation of de-
veloping cartilage. Only cells
cultured on Pln stained posi-
tively with Alcian blue (com-
pare C and D) and expressed
collagen type II protein detected
with II6B3 antibody (compare E
and F). Magnification for A–D
is indicated in C, and mag-
nification for E and F is indi-
cated in E.The Journal of Cell Biology, Volume 145, 1999 1112
bound growth factors (McCaffrey et al., 1992) had no ef-
fect on this inductive activity. From these assays, inductive
activity appears to be dependent in part on both the Pln
core protein and the HS chains. This may account for the
lack of inductive activity in some Pln preparations. If cells
require interaction with both the HS chains and the core
protein to elicit a full response, one or the other interac-
tion might act to block stimulation from another source.
Thus, contact with the core protein of inactive Pln primes
Figure 8. Internal expression of chondrocyte markers by 10T1/2 aggregates. 10T1/2 cells were cultured for 7 d on Pln (A–D) or plastic
(E and F). Aggregates from cultures on Pln or scraped cells from cultures on plastic were sectioned and probed for different chondro-
cyte markers. Alcian blue staining (A) is present in regions throughout the aggregate. Hematoxylin and eosin staining of aggregates (B)
demonstrates a nonfibroblastic morphology compared with a culture from tissue culture plastic (F). Collagen type II detected with rab-
bit anti–mouse antibody from Chemicon (C) and aggrecan (D) are also present within the aggregate. Cells cultured on plastic fail to ex-
press similar levels of collagen type II (E). Bars, A, 100 mm; B and F, 250 mm; C, 800 mm; D and E, 200 mm.
Table I. Effects of ECM Components on 10T1/2
Aggregate Formation
Plating material Result Plating material Result
ECM components Glycosaminoglycans
Laminin 0 HP 0
Collagen type IV 0 Bovine kidney HS 0
Laminin 1 collagen type IV 0 Bovine intestinal mucosa HS 0
Fibronectin 0 CS 0
Pln 3 HP–BSA 1
Pln 1 heparinase 1 Other
Pln 1 chondroitinase ABC 3
Pln 1 NaCl wash 3 BSA 0
Matrigel 1 PBS 0
10T1/2 cells were cultured on surfaces coated with the indicated ECM components.
Differentiation was scored on the basis of the formation of cell aggregates and Alcian
blue staining as shown below. 0 5 no aggregates formed; 1 5 inefficient cell recruit-
ment into aggregates; 2 5 efficient recruitment of all cells with nonuniform or incom-
plete aggregate staining with Alcian blue; 3 5 efficient recruitment of cells into ag-
gregates, uniform aggregate staining with Alcian blue.
Table II. Growth Factors Do Not Restore 10T1/2 Aggregate 
Formation on Inactive Pln Preparations
Growth factor Plating material Result
bFGF PBS 0
1 ng/ml I-Pln 0
BMP-2 PBS 0
1 ng/ml I-Pln 0
BMP-4 PBS 0
1 ng/ml I-Pln 0
BMP-2 1 -4 PBS 0
1 ng/ml I-Pln 0
TGF-b PBS 0
1 ng/ml I-Pln 0
Growth factors were added to a Pln preparation lacking aggregate-inducing activity
(I-Pln). Growth factors were scored using the scoring index described in Table I.French et al. Perlecan in Chondrogenesis 1113
the 10T1/2 cells to respond to stimulation from a linked
HS chain. In the absence of the chain, the cell may be un-
able to respond to TGF-b or BMP-4 signals. Variations in
isolation protocols or the actions of tissue heparanases
during isolation could account for a depletion of specific
classes of HS structures in these preparations. A prefer-
ence for more highly negative molecules containing L-idu-
ronic acid by differentiating chondrocytes in micromass
culture has been demonstrated by SanAntonio et al.
(1987). If larger and more negatively charged HS chains
were selected against in the isolation process, or were de-
graded by tissue heparanases during isolation, the stimula-
tory effect of Pln might be lost or reduced. Another possi-
bility is the large Pln core protein may become partially
denatured or otherwise modified at subtle, yet critical,
sites during isolation.
A simple model for the action of Pln on chondrogenesis
focuses on attachment of the cells to a matrix. If cell–
matrix interactions are impaired, then the cells would re-
main more rounded and attach to each other rather than
the matrix, forming aggregates. When cultures from chick
limb buds were supplemented with soluble HS or HP, in-
creased aggregate formation and sulfate incorporation,
Figure 10. Induction of chon-
drogenic phenotype by enzy-
matically modified Pln. 10T1/2
cells were cultured on tissue
culture plastic (A), Pln (B),
Pln treated with chondroiti-
nase (C), or Pln treated with
heparinases (D) for 7 d. Both
the cells on Pln and on chon-
droitinase-treated Pln rap-
idly formed aggregates that
stain positively with Alcian
blue. In contrast, 10T1/2 cells
on heparinase-treated Pln
form aggregates poorly, and
fail to stain strongly with Al-
cian blue. Bar, 500 mm.
Figure 11. Kinetics of cell aggregation on Pln. Cells cultured on
Pln for the indicated number of days were inspected for both re-
cruitment of cells into aggregates and staining with Alcian blue
using the scoring index described in Table I. Balb-c 3T3 cells ag-
gregate, but not all aggregates stain with Alcian blue. 10T1/2 cells
rapidly form aggregates that all stain with Alcian blue and this
process is unaffected by chondroitinase treatment of the Pln. In
contrast, heparinase digestion of Pln reduces the rate and the ex-
tent of the response by the cells.
Figure 9. Analysis of chondrocyte marker expression by RT-
PCR. RNA from 10T1/2 cells cultured on tissue culture plastic
(lanes 1 and 3) or Pln (lanes 2 and 4) for 9 d was reverse tran-
scribed and products for collagen types I (Col I) and II (Col II)
amplified. As a positive control for the assay, product for the ri-
bosomal protein L19 was also amplified. Cells cultured on plastic
or Pln express similar levels of collagen type I mRNA; however,
cells cultured on Pln express much higher levels of mRNA for the
chondrocyte marker, collagen type II.The Journal of Cell Biology, Volume 145, 1999 1114
i.e., glycosaminoglycan synthesis, was observed (SanAnto-
nio et al., 1987). In these studies, it was suggested that a
possible effect of the HS/HP was to free the cells from
their attachment to the matrix, allowing them to round up
and promoting cell–cell interaction. The induction of
chondrogenesis observed in the present studies is more
complex. Induction of chondrogenesis in vitro appears to
require some specific interaction and binding to Pln. 10T1/2
cells attach, but do not spread, on Pln. Also, Pln can main-
tain human chondrocytes in their differentiated form in
vitro. In contrast, human fibroblasts do not attach to or
differentiate on Pln-coated surfaces. It remains unclear
which receptor systems trigger chondrogenesis in vitro.
Such systems appear to involve both HS- and Pln-recog-
nizing events. Complexes containing integrin subunits av,
b3, and b1 have been reported to bind Pln, although Pln
lacking HS chains appeared to be more effectively recog-
nized (Hayashi et al., 1992). These integrin subunits also
have been detected in developing cartilage (Woods et al.,
1994).
While several potential chondrogenic factors have been
identified, none of these factors have been examined in
the context of interactions with the extracellular matrix
surrounding the cells in vivo. In this study, examination of
temporal and spatial patterns of the extracellular matrix
protein, Pln, supports a role for this protein in the program
Figure 12. Maintenance of
human chondrocytes by Pln.
Human chondrocytes were
cultured on either tissue cul-
ture plastic (A, B, and G) or
Pln (C, D, and F) for 7 d and
probed with antibodies recog-
nizing aggrecan (C) or col-
lagen type II detected by
mouse mAb from Chemicon
(F). On plastic, chondrocytes
express low levels of aggrecan
and appear fibroblastic. On
Pln, aggrecan protein is dis-
cretely localized to specific
cells and aggregates. The
morphology, more rounded
and aggregated, is typical of
chondrocytes. Human fibro-
blasts do not adhere to Pln
(E). Chondrocytes on plastic
(G) and Pln (H) stained with
hematoxylin and eosin. Bar,
100 mm. Magnification for
A–F is indicated in B.French et al. Perlecan in Chondrogenesis 1115
of maturation or maintenance of chondrocytes. The com-
bination of appropriate extracellular matrix molecules
with various growth factors, secreted either by chondro-
cytes or surrounding cells, may prove to be an essential
mix for development of cartilage in vivo.
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